We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+2.74%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$747M
AUM Growth
-$68.4M
Cap. Flow
-$45M
Cap. Flow %
-6.03%
Top 10 Hldgs %
35.25%
Holding
111
New
12
Increased
44
Reduced
34
Closed
21

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$16.1M
2
PODD icon
Insulet
PODD
+$15.9M
3
ICLR icon
Icon
ICLR
+$11.6M
4
HUM icon
Humana
HUM
+$10.1M
5
BSX icon
Boston Scientific
BSX
+$9.23M

Top Sells

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$17.4M
2
THC icon
Tenet Healthcare
THC
+$16.2M
3
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$15.6M
4
COR icon
Cencora
COR
+$13.9M
5
OSCR icon
Oscar Health
OSCR
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 98.27%
2 Industrials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THRD
76
DELISTED
Third Harmonic Bio
THRD
$1.73M 0.23%
133,325
+93,325
+233% +$1.15M
ANNX icon
77
Annexon
ANNX
$873M
$1.6M 0.21%
326,845
-19,842
-6% -$103K
EPIX
78
DELISTED
ESSA Pharma
EPIX
$1.33M 0.18%
252,072
+377
+0.1% +$2.4K
ARDX icon
79
Ardelyx
ARDX
$1.03B
$1.11M 0.15%
150,192
-49,808
-25% -$350K
VKTX icon
80
Viking Therapeutics
VKTX
$3.97B
$1.08M 0.14%
20,372
-9,926
-33% -$651K
AKYA
81
DELISTED
Akoya BioSciences
AKYA
$879K 0.12%
375,536
-541,906
-59% -$1.73M
ETON icon
82
Eton Pharmaceutcials
ETON
$1.14B
$833K 0.11%
253,197
+54,029
+27% +$189K
ENTX icon
83
Entera Bio
ENTX
$138M
$739K 0.1%
+401,518
New +$879K
YARW
84
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
$680K 0.09%
6,904
-7,025
-50% -$876K
RVPH
85
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$646K 0.09%
25,230
+37
+0.1% +$1.68K
AUGX
86
DELISTED
Augmedix, Inc. Common Stock
AUGX
$499K 0.07%
566,845
-499,264
-47% -$1.03M
XFOR icon
87
X4 Pharmaceuticals
XFOR
$425M
$468K 0.06%
26,887
+42
+0.2% +$1.37K
TELA icon
88
TELA Bio
TELA
$32.3M
$460K 0.06%
97,816
+148
+0.2% +$780
TKNO icon
89
Alpha Teknova
TKNO
$397M
$406K 0.05%
296,652
+450
+0.2% +$856
XERS icon
90
Xeris Biopharma Holdings
XERS
$1.55B
$227K 0.03%
100,830
+154
+0.2% +$310
ABOS icon
91
Acumen Pharmaceuticals
ABOS
$181M
– –
-576,657
Closed -$2.34M
BFLY icon
92
Butterfly Network
BFLY
$2.52B
– –
-750,000
Closed -$810K
CGEM icon
93
Cullinan Oncology
CGEM
$1.26B
– –
-178,396
Closed -$3.04M
CNC icon
94
Centene
CNC
$33.1B
– –
-55,794
Closed -$4.38M
CRL icon
95
Charles River Laboratories
CRL
$13.6B
– –
-17,697
Closed -$4.8M
CYTK icon
96
Cytokinetics
CYTK
$10.5B
– –
-20,160
Closed -$1.41M
ETNB
97
DELISTED
89bio
ETNB
– –
-179,899
Closed -$2.09M
HCA icon
98
HCA Healthcare
HCA
$89.8B
– –
-35,283
Closed -$11.8M
IDYA icon
99
IDEAYA Biosciences
IDYA
$3.56B
– –
-66,332
Closed -$2.91M
INSP icon
100
Inspire Medical Systems
INSP
$1.68B
– –
-81,183
Closed -$17.4M
1 2 3
4
5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Parkman Healthcare Partners held 111 positions worth $747M, down 8.4% from $815M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parkman Healthcare Partners withdrew a net $45M in Q2 2024, closing 21 positions and reducing 34 holdings. Its most notable exit was Inspire Medical Systems, an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 99% a quarter earlier, followed by Industrials.

Against the trend, Parkman Healthcare Partners opened a new position in Agios Pharmaceuticals worth $19.2M.

  • Parkman Healthcare Partners's largest Q2 2024 buy was Agios Pharmaceuticals: 446,416 shares worth $19.2M.
  • Parkman Healthcare Partners added most to Insulet in Q2 2024, an estimated $15.9M increase.
  • Parkman Healthcare Partners's biggest Q2 2024 reduction was Tenet Healthcare, cutting an estimated $16.2M.
  • Parkman Healthcare Partners fully exited Inspire Medical Systems in Q2 2024, selling an estimated $17.4M.
  • Parkman Healthcare Partners's ten largest holdings make up 35% of its $747M portfolio in Q2 2024.
  • Parkman Healthcare Partners opened 12 new positions and closed 21 in Q2 2024.
  • Parkman Healthcare Partners's portfolio value fell 8.4% quarter-over-quarter to $747M.

Based on Parkman Healthcare Partners's 13F filing for Q2 2024, filed 14 Aug 2024.